S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
Critical asset just had biggest fall on record (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
Critical asset just had biggest fall on record (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Closing prices for crude oil, gold and other commodities
U.S. "Shadow Banks" About to Blow up again? (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
Critical asset just had biggest fall on record (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
Critical asset just had biggest fall on record (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Closing prices for crude oil, gold and other commodities
U.S. "Shadow Banks" About to Blow up again? (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
Critical asset just had biggest fall on record (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
Critical asset just had biggest fall on record (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Closing prices for crude oil, gold and other commodities
U.S. "Shadow Banks" About to Blow up again? (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
Critical asset just had biggest fall on record (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
Critical asset just had biggest fall on record (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Closing prices for crude oil, gold and other commodities
U.S. "Shadow Banks" About to Blow up again? (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
NASDAQ:ZYXI

Zynex (ZYXI) Stock Price, News & Analysis

$12.91
+0.02 (+0.16%)
(As of 02/23/2024 ET)
Today's Range
$12.83
$13.03
50-Day Range
$9.86
$12.91
52-Week Range
$6.88
$14.75
Volume
155,386 shs
Average Volume
250,838 shs
Market Capitalization
$437.70 million
P/E Ratio
30.02
Dividend Yield
N/A
Price Target
$20.33

Zynex MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
57.5% Upside
$20.33 Price Target
Short Interest
Bearish
30.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.50mentions of Zynex in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
37.50%
From $0.40 to $0.55 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.99 out of 5 stars

Medical Sector

374th out of 939 stocks

Electromedical Equipment Industry

6th out of 21 stocks


ZYXI stock logo

About Zynex Stock (NASDAQ:ZYXI)

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

ZYXI Stock Price History

ZYXI Stock News Headlines

Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call
Gold is SOARING – here's what you need to do
Everything is lining up perfectly for a historic gold bull run. One gold expert says he's found the best way to get in, for just $5.
Zynex Introduces New Products
Zynex Introduces New Products
Zynex Says FDA Clears M-Wave Neuromuscular Electrical Stimulation Device
Gold is SOARING – here's what you need to do
Everything is lining up perfectly for a historic gold bull run. One gold expert says he's found the best way to get in, for just $5.
3 Unloved Growth Stocks Poised for a Major Turnaround
Zynex To Buy Back Up To $20 Mln Of Common Stock
Zynex Announces Review of Strategic Alternatives
RBC Capital Reaffirms Their Buy Rating on Zynex (ZYXI)
Zynex Reports Third Quarter 2023 Financial Results
See More Headlines
Receive ZYXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/13/2023
Today
2/24/2024
Next Earnings (Estimated)
3/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:ZYXI
Fax
N/A
Employees
900
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$20.33
High Stock Price Target
$28.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+57.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$17.05 million
Pretax Margin
10.96%

Debt

Sales & Book Value

Annual Sales
$158.17 million
Cash Flow
$0.55 per share
Book Value
$1.77 per share

Miscellaneous

Free Float
18,118,000
Market Cap
$437.65 million
Optionable
Optionable
Beta
0.49
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report














ZYXI Stock Analysis - Frequently Asked Questions

Should I buy or sell Zynex stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ZYXI shares.
View ZYXI analyst ratings
or view top-rated stocks.

What is Zynex's stock price target for 2024?

3 brokers have issued 1-year price targets for Zynex's shares. Their ZYXI share price targets range from $13.00 to $28.00. On average, they expect the company's share price to reach $20.33 in the next year. This suggests a possible upside of 57.5% from the stock's current price.
View analysts price targets for ZYXI
or view top-rated stocks among Wall Street analysts.

How have ZYXI shares performed in 2024?

Zynex's stock was trading at $10.89 at the beginning of the year. Since then, ZYXI shares have increased by 18.5% and is now trading at $12.91.
View the best growth stocks for 2024 here
.

When is Zynex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 4th 2024.
View our ZYXI earnings forecast
.

How were Zynex's earnings last quarter?

Zynex, Inc. (NASDAQ:ZYXI) issued its quarterly earnings results on Monday, March, 13th. The company reported $0.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.19 by $0.01. The business had revenue of $48.81 million for the quarter, compared to analysts' expectations of $49.65 million. Zynex had a trailing twelve-month return on equity of 25.38% and a net margin of 8.59%.

What ETF holds Zynex's stock ?

Syntax Stratified SmallCap ETF holds 8,191 shares of ZYXI stock, representing 0.42% of its portfolio.

What is Thomas Sandgaard's approval rating as Zynex's CEO?

81 employees have rated Zynex Chief Executive Officer Thomas Sandgaard on Glassdoor.com. Thomas Sandgaard has an approval rating of 87% among the company's employees.

Who are Zynex's major shareholders?

Zynex's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.48%), HAP Trading LLC (0.00%), Northern Trust Corp (0.56%), GSA Capital Partners LLP (0.47%), Goldman Sachs Group Inc. (0.42%) and Charles Schwab Investment Management Inc. (0.37%). Insiders that own company stock include Anna Lucsok, Daniel J Moorhead and Thomas Sandgaard.
View institutional ownership trends
.

How do I buy shares of Zynex?

Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ZYXI) was last updated on 2/24/2024 by MarketBeat.com Staff